After making a presentation before one of Wall Street's key biotech investment conferences, Lynne Parshall, chief operating officer of Isis Pharmaceuticals Inc. (Nasdaq: ISIS), will ring the closing bell at the Nasdaq stock exchange Friday.
The bell-ringing follows Isis' presentation at the annual Leerink Swann Healthcare Conference. Despite some recent positive news for the company -- including a Food and Drug Administration green light for one of its drugs -- the stock price barely rose during the presentation, which was webcast live.
1896 Rutherford Road
Carlsbad, CA 92008